£60.99

CRC Press The Benefit/Risk Ratio: A Handbook for the Rational Use of Potentially Hazardous Drugs

Price data last checked 9 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£61 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 82 days · 82 data points (no recent data)

Historical
Generating forecast…
£62.39 £60.85 £61.19 £61.52 £61.86 £62.19 £62.53 26 April 2026 16 May 2026 05 June 2026 25 June 2026 16 July 2026

Price Distribution

Price distribution over 82 days • 2 price levels

Days at Price
Current Price
1 day · current 81 days 0 20 41 61 81 £61 £62 Days at Price

Price Analysis

Most common price: £62 (81 days, 98.8%)

Price range: £61 - £62

Price levels: 2 different prices over 82 days

Description

The use of drugs as remedies for various types of diseases has a long tradition; however, it has only been recently recognized that the value of any given compound must be evaluated in light of its benefit to risk ratio. When prescribing drugs, physicians must look at the big picture of the drug's benefits in relation to its side effects and possible toxicity. The aim of this handbook is to compile data from various authors, providing clinicians with data that will optimize their decision making in selecting effective, low-risk drug treatments. It also provides research workers, including physicians, pharmacists, and basic scientists, with a sound basis for increasing knowledge of the risk/benefit ratios of various drugs. Includes detailed assessments of the following types of drugs: Antihypertensive agents Diuretics Anti-diabetic drugs Anticonvulsant drugs Drugs for Parkinson's disease Antihistamines and antiserotonins Cytokines and immunomodulators Non-opioid analgesics and anti-inflammatory agents Antibacterial agents Antiviral agents Drugs used in reproductive endocrinology Systemic drugs for skin diseases Topical liposome drugs Topical glucocorticoids

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
30 June 2020
Listed Since
15 May 2020

Barcode

No barcode data available

Similar Products You Might Like

The Benefit/Risk Ratio: A Handbook for the Rational Use of Potentially Hazardous Drugs
99% match

The Benefit/Risk Ratio: A Handbook for the Rational Use of Potentially Hazardous Drugs

CRC Press

£161.14 10 Jul 2026
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
95% match

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£75.00 04 Jul 2026
Advanced Issue Resolution in Safety Pharmacology
95% match

Advanced Issue Resolution in Safety Pharmacology

Academic Press

£117.99 10 Jul 2026
Basic Concepts in Pharmacology: What You Need to Know for Each Drug Class, Sixth Edition
94% match

Basic Concepts in Pharmacology: What You Need to Know for Each Drug Class, Sixth Edition

McGraw-Hill Education

£46.64 02 Jul 2026
Drug Information: A Guide for Pharmacists, Fourth Edition
94% match

Drug Information: A Guide for Pharmacists, Fourth Edition

McGraw-Hill Education

£41.99 11 Jul 2026
Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)
94% match

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£80.00 14 Jul 2026
Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
94% match

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£61.46 08 Jul 2026
Katzung & Trevor's Pharmacology Examination & Board Review, Fourteenth Edition
94% match

Katzung & Trevor's Pharmacology Examination & Board Review, Fourteenth Edition

McGraw-Hill Education

£30.69 26 Jun 2026
Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)
94% match

Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£50.99 02 Jul 2026
Medications for Older Persons: Recommendations, Harms, Evidence
94% match

Medications for Older Persons: Recommendations, Harms, Evidence

Academic Press

£112.99 10 Jul 2026
Guide Pratique Des Médicaments Dorosz 2019
94% match

Guide Pratique Des Médicaments Dorosz 2019

MALOINE

£57.77 03 Jul 2026
Receptor - Based Drug Design: 89 (Drugs and the Pharmaceutical Sciences)
94% match

Receptor - Based Drug Design: 89 (Drugs and the Pharmaceutical Sciences)

CRC Press

£62.99 08 Jul 2026
2021 Nurse's Drug Handbook
94% match

2021 Nurse's Drug Handbook

Jones & Bartlett Learning

£46.95 08 Jul 2026
Post-Authorization Safety Studies of Medicinal Products: The PASS Book
94% match

Post-Authorization Safety Studies of Medicinal Products: The PASS Book

Academic Press

£87.48 15 Jul 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)
94% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£85.00 09 Jul 2026
Essential Clinical Pharmacology
94% match

Essential Clinical Pharmacology

Springer

£82.05 13 Jul 2026
Principles of Clinical Pharmacology
94% match

Principles of Clinical Pharmacology

Academic Press

£76.00 04 Jul 2026
A Manual of Adverse Drug Interactions
94% match

A Manual of Adverse Drug Interactions

Elsevier

£250.00 13 Jul 2026